Cornell University, in partnership with Memorial Sloan Kettering Cancer Center, is opening a new $10 million MSKCC-Cornell Center for Translation of Cancer Nanomedicines. The center is based on development of nanoparticles called C dots.
Cornell President Elizabeth Garrett heralded a future of greater collaboration between Ithaca and New York City at a Sept. 21 reception in honor of her inauguration as the university’s 13th president.
Researchers described their cutting-edge research at a biomedical engineering symposium, “Understanding and Treating Disease: Inspirations from Womb to Tomb,” on campus Sept. 16.
Monika Safford, M.D. ’86, has been named chief of the Division of General Internal Medicine at Weill Cornell Medical College and NewYork-Presbyterian/Weill Cornell Medical Center.
Minimally Invasive New Technologies Program (MINT) at Weill Cornell Medical College teamed with entrepreneurs to establish Lumendi, a start-up producing endoscopic tools for gastrointestinal surgery.
Sam Tilsen, assistant professor of linguistics, and colleagues used real-time magnetic resonance imaging to document anticipated vocal responses via the positions of vocal organs.
Researchers at the Caryl and Israel Englander Institute for Precision Medicine at Weill Cornell Medical College use genomic sequencing to understand factors that drive disease development and identify treatments most likely to be effective for each patient.
In a banner year for fundraising, Cornell University raised $672.9 million in fiscal 2015 that ended June 30, vaulting the Cornell Now campaign above $6 billion and setting new records for dollars raised and participation.
A Weill Cornell Medical College study in Neurosurgery suggests that gender-specific genes and other epigenetic factors might influence the formation and development of pediatric brain cancers.
